Body composition, physical exercise, growth hormone and obesity

Eating and Weight Disorders

Volumn 6, Issue 3 SUPPL., 2001, Pages 28-37

  Weltman, A ^a   Weltman, J Y ^a   Veldhuis, J D ^a   Hartman, M L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; AGED; AGING; BODY COMPOSITION; EXERCISE; HORMONE SUBSTITUTION; HUMAN; LOW CALORY DIET; OBESITY; PATHOPHYSIOLOGY; REVIEW; SECRETION;

ADULT; AGED; AGING; BODY COMPOSITION; DIET, REDUCING; EXERCISE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; OBESITY;

EID: 0035464447     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Chumlea W.C., Guo S.S.: Assessment and prevalence of obesity. Endocrine, 13, 135-142, 2000.
2. Guistina A., Veldhuis J.D.: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev., 19, 717-797, 1998.
3. Hartman M.L.: Physiological regulators of growth hormone secretion. In: Juul A., J0rgensen J.O.L. (Eds), Growth Hormone in Adults, ed. 2, Cambridge, Cambridge University Press, 2000, pp. 3-53.
4. Martha P.M., Gorman K.M., Blizzard R.M., Rogol A.D., Veldhuis J.D.: Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J. Clin. Endocrinol. Metab., 74, 336-344, 1992.
5. Roemmich J.N., Clark P.N., Mai V., Berr S., Weltman A., Veldhuis J.D., Rogol A.D.: Alterations in growth and body composition during puberty: III. Influence of maturation, gender, body composition, fat distribution, aerobic fitness, and energy expenditure on nocturnal growth hormone release. J. Clin. Endocrinol. Metab., 83, 1440-1447, 1998.
6. Iranmanesh A., Lizarralde G., Veldhuis J.D.: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab., 73, 1081-1088, 1991.
7. Veldhuis J.D., Liem A.Y., South S., Weltman A., Weltman J., Clemmons D.R., Abbott R., Mulligan T., Johnson M.L, Pincus S., Straume M., Iranmanesh A.: Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemilu-minescence assay. J. Clin. Endocrinol. Metab., 80, 3209-3222, 1995.
8. Hartman M.L., Veldhuis J.D., Johnson M.L., Lee M.M., Alberti K.G.M.M., Samojlik E., Thorner M.O.: Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two day fast in normal men. J. Clin. Endocrinol. Metab., 74, 757-765, 1992.
9. Weltman A., Weltman J.Y., Hartman M.L., Abbott R.D., Rogol A.D., Evans W.S., Veldhuis J.D.: Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J. Clin. Endocrinol. Metab., 78, 543-548, 1994.
10. Vahl N., Jørgensen J.O.L., Skjœrbaek C, Veldhuis J. D., Ørskov H., Christiansen J.S.: Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am. J. Physiol., 272, E1108-E1116, 1997.
11. Iranmanesh A., South S., Liem A.Y., Clemmons D., Thorner M.O., Weltman A., Veldhuis J.D.: Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur. J. Endocrinol., 139, 59-71, 1998.
12. Vahl N., Jørgensen J.O.L., Jurik A.G., Christiansen J.S.: Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J. Clin. Endocrinol. Metab., 81, 2209-2215, 1996.
13. Després J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis, 10, 497-511, 1990.
14. Rasmussen M.H., Frystyk J., Andersen T., Breum L., Christiansen J.S., Hilsted J.: The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism, 43, 315-319, 1994.
15. Clasey J.L., Weltman A., Patrie J., Weltman J.Y., Pezzoli S., Bouchard C., Thorner M.O., Hartman M.L.: Abdominal visceral fat and fasting insulin are important predictors of 24-hour growth hormone release independent of age, gender, and other physiological factors. J. Clin. Endocrinol. Metab. (In press)
16. Weltman A., Després J.P., Clasey J., Weltman J.Y., Wideman L., Kanaley J., Patrie J., Bergeron J., Thorner M.O., Bouchard C, Hartman M.L.: Impact of abdominal visceral fat (AVF), growth hormone (GH), fitness, and insulin on lipids and lipoproteins in older adults. J. Clin. Endocrinol. Metab. (In review)
17. Bengtsson B.A., Eden S., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjöstrom L., Isaksson O.G.: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab., 76, 309-317, 1993.
18. De Boer H., Blok G.J., Van der Veen E.A.: Clinical aspects of growth hormone deficiency in adults. Endocr. Rev., 16, 63-86, 1995.
19. Reichlin S.: Regulation of somatotrophic hormone secretion. In: Greep R.O., Astwood E.B. (Eds.), Handbook of Physiology. Sect. 7. Endocrinology. Washington, DC, American Physiological Society, 1974, vol. 4, pp. 405-447.
20. Williams T., Berelowitz M., Joffe S.N., Thorner M.O., Rivier J., Vale W., Frohman L. A.: Impaired growth hormone responses to growth hormone-releasing factor in obesity: a pituitary defect reversed with weight reduction. N. Engl. J. Med., 311, 1403-1407, 1984.
21. Kelijman M., Frohman L.A.: Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J. Clin. Endocrinol. Metab., 66, 489-494, 1988.
22. De Marinis L., Folli G., D'Amico C, Mancini A., Sambo P., Tofani A., Oradei A., Barbarino A.: Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. J. Clin. Endocrinol. Metab., 66, 598-604, 1988.
23. Tanaka K., Inoue S., Numata K., Okazaki H., Nakamura S., Takamura Y.: Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion responses to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism, 39, 892-896, 1990.
24. Cordido F., Dieguez C, Casanueva F.F.: Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by Clonidine, arginine, or hypoglycemia in normal and obese subjects. J. Clin. Endocrinol. Metab., 70, 1361-1370, 1990.
25. Cordido F., Penalva A., Dieguez C, Casanueva F.F.: Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J. Clin. Endocrinol. Metab., 76, 819-823, 1993.
26. Maccario M., Valetto M.R., Savio P., Aima-retti G., Baffoni C., Procopio M., Grottoli S., Oleandri S.E., Arvat E., Ghigo E.: Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Int. J. Obes. Relat. Metab. Disord., 21, 27-32, 1997.
27. Maccario M., Guana C, Procopio M., Di Vito L., Rosssetto R., Oleandri S.E., Grottoli S., Ganzaroli C., Aimaretti G., Ghigo E.: Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH plus arginine test. J. Endocrinol. Invest., 22, 424-429, 1999.
28. Tschop M., Weyer C, Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L.: Circulating Ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709, 2001.
29. Crockford P.M., Salmon P.A.: Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss. Canadian Medical Association Journal, 103, 147-150, 1970.
30. Ball M.F., el-Khodary A.Z., Canary J.J.: Growth hormone response in the thinned obese. J. Clin. Endocrinol. Metab., 34, 498-511, 1972.
31. Rasmussen M.H., Hvidberg A., Juul A., Main K.M., Gotfredsen A., Skakkebaek N. E., Hilsted J.: Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J. Clin. Endocrinol. Metab., 80, 1407-1415, 1995.
32. Veldhuis J.D., Iranmanesh A., Ho K.K.Y., Waters M.J., Johnson M.L., Lizarralde G.: Dual defects in pulsatile growth hormone secretion and clearance subserve the hypo-somatotropism of obesity in man. J. Clin. Endocrinol. Metab., 72, 51-59, 1991.
33. Rasmussen M.H., Juul A., Kjems L.L., Skakkebaek N.E., Hilsted J.: Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J. Clin. Endocrinol. Metab., 80, 796-801, 1995.
34. Riedel M., Hoeft B., Blum W.F., von zur Mühlen A., Brabant G.: Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism, 44, 605-610, 1995.
35. th Meeting of the Endocrine Society, 155, 1995, abstract Pl-P172.
36. Kohno H., Ueyama N., Honda S.: Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults. Diabetes Obesity & Metabolism, 1, 293-296, 1999.
37. Rudman D., Feller A.G., Nagraj H.S., Gergans G.A., Lalitha P.Y., Goldberg A.Y., Schlenker R.A., Cohn L., Rudman I.W., Mattson D.E.: Effects of human growth hormone in men over 60 years old. N. Engl. J. Med., 323, 1-6, 1990.
38. th International Congress of Endocrinology, Sydney, Australia, October 29 - November 2, 2000, abstract P434, p. 201.
39. Holloway L., Butterfield G., Hintz R.L., Gesundheit N., Marcus R.: Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J. Clin. Endocrinol. Metab., 79, 470-479, 1994.
40. Papadakis M.A., Grady D., Black D., Tierney M.J., Gooding G.A.W., Schambelan M., Grunfeld C: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med., 124, 708-716, 1996.
41. Taffe D.R., Lewis B., Marcus R.: Regional fat distribution by dual-energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise. Clin. Sci., 87, 581-586, 1994.
42. Taffe D.R., Pruitt L., Reim J., Hintz R.L., Butterfield G:, Hoffman A.R., Marcus R.: Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J. Clin. Endocrinol. Metab., 79, 1361-1366, 1994.
43. Yarasheski K.E., Zachwieja J.J., Campbell J.A., Bier D.M.: Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am. J. Physiol., 268, E268-E276, 1995.
44. th International Congress of Endocrinology, Sydney, Australia, October 29 - November 2, 2000, abstract P435, p. 201.
45. Ottosson M., Lonnroth P., Björntorp P., Eden S.: Effects of Cortisol and growth hormone on lipolysis in human adipose tissue. J. Clin. Endocrinol. Metab., 85, 799-803, 2000.
46. Kamel A., Norgren S., Elimam A., Danielssson P., Marcus C: Effects of growth hormone treatment in obese prepubertal boys. J. Clin. Endocrinol. Metab., 85, 1412-1419, 2000.
47. Johannsson G., Marin P., Lonn L., Ottosson M., Stenlof K., Björntorp P., Sjostrom L., Bengtsson B.A.: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab., 82, 727-734, 1997.
48. Svensson J., Bengtsson B.A., Taskinen M.R., Wiklund O., Johannsson G.: A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Hormone & IGF Research, 10, 118-126, 2000.
49. Svensson J., Lonn L., Jansson J.O., Murphy G., Wyss D., Krupa D., Cerchio K., Pomno W., Gertz B., Boseaus I., Sjöström L., Bengtsson B.A.: Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab., 83, 362-369, 1998.
50. Johansson J.O., Oscarsson J., Bjarnsson R., Bengtsson B.A.: Two weeks of daily injections of continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. I. Effects on insulin-like growth factor-I (IGF-I), GH, and IGF-binding proteins, and glucose homeostasis. Metabolism, 45, 362-369, 1996.
51. Svennson J., Jansson J.O., Ottosson M., Johannsson G., Taskinen M.R., Wiklund O., Bengtsson B.A.: Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins but not lipoprotein (a). J. Clin. Endocrinol. Metab., 84, 2028-2033, 1999.
52. Thompson J.L., Butterfield G.E., Gylfadottir U.K., Yesavage J., Marcus R., Hintz R.L., Pearman A., Hoffman A.R.: Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J. Clin. Endocrinol. Metab., 83, 1477-1484, 1998.
53. Kim K.R., Nam S.Y., Song Y.D., Um S.K., Lee H.C., Huh, K.B.: Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm. Res. 51, 78-84, 1999.
54. Norrelund H., Borglum J., Jorgensen J.O.L., Richelsen B., Moller N., Nair K.S., Christiansen J.S.: Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women. Clin. Endocrinol., 52, 305-312, 2000.
55. Kanaley J.A., Weltman J.Y., Veldhuis J.D., Rogol A.D., Hartman M.L., Weltman A. Human growth hormone response to repeated bouts of aerobic exercise. J. Appl. Physiol., 83, 1756-1761, 1997.
56. Weltman A., Weltman J.Y., Womack C.J., Davis S.E., Blumer J.L., Gaesser G.A., Hartman M.L.: Exercise training decreases the growth hormone (GH) response to acute constant-load exercise. Med. Sci. Sports Exerc, 29, 669-676, 1997.
57. Pritzlaff C.J., Wideman L., Weltman J.Y., Abbott R.D., Gutgesell M.E., Hartman M.L., Veldhuis J.D., Weltman A. Impact of exercise intensity on pulsatile growth hormone release in men. J. Appl. Physiology, 87, 498-504, 1999.
58. Pritzlaff C.J., Wideman L., Weltman J.Y., Abbott R.D., Gutgesell M.E., Hartman MX, Veldhuis J.D., Weltman A.: Gender governs the relationship between exercise intensity and growth hormone release in young men and women. J. Appl. Physiol. (In review)
59. Wideman L., Weltman J.Y., Shah N., Story S., Veldhuis J.D., Weltman A.: Effects of gender on exercise-induced growth hormone (GH) release. J. Appl. Physiol., 87, 1154-1162, 1999.
60. Wideman L., Weltman J.Y, Patrie J., Bowers C.Y., Shah N., Story S., Veldhuis J.D., Weltman A.: Synergy of L-arginine and GHRP-2 stimulation of growth hormone (GH) in men and women: Modulation by exercise. Am. J. Physiol., 279, R1467-R1477, 2000.
61. Sutton J., Lazarus L.: Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J. Appl. Physiol., 41, 523-527, 1976.
62. Bunt J.C., Boileau R.A., Bahr J.M., Nelson R.A.: Sex and training differences in human growth hormone during prolonged exercise. J. Appl. Physiol, 61, 1796-1801, 1986.
63. Chang F.E., Dodds W.G., Sullivan M., Kim M.H., Malarkey W.B.: The acute effects of exercise on prolactin and growth hormone secretion: comparison between sedentary women and women runners with normal and abnormal menstrual cycles. J. Clin. Endocrinol. Metab. 62, 551-556, 1986. '
64. Vanhelder W.P., Casey K., Radomski M.W.: Regulation of growth hormone during exercise by oxygen demand and availability. Eur. J. Appl. Physiol, 56, 628-632, 1987.
65. Felsing N.E., Brasel J.A., Cooper D.M.: Effect of low and high intensity exercise on circulating growth hormone in men. J. Clin. Endocrinol. Metab., 75, 157-162, 1992.
66. Thompson D.L., Weltman J.Y., Rogol A.D., Metzger D.L., Veldhuis J.D., Weltman A.: Cholinergic and opioid involvement in release of growth hormone during exercise and recovery. J. Appl. Physiol, 75, 870-878, 1993.
67. Weltman A., Pritzlaff C, Weltman J.Y., Abbott R., Gutgesell M., Veldhuis J.D., Hartman M.L.: The relationship between exercise intensity and growth hormone (GH) release is attenuated in older men. Presented at Growth Hormone Research Society, Göteborg, Sweden, 2000.
68. Weltman A., Anderson S.M., Wideman L., Weltman J.Y., Veldhuis J.D.: Impact of short-term estrogen supplementation in postmenopausal women on spontaneous and exercise-stimulated pulsatile growth hormone secretion. Presented at The Endocrine Society, Denver, Colorado, USA, 2001.
69. Cappon J.P., Ipp E., Brasel J.A., Cooper D.M.: Acute effects of high fat and high glucose meals on the growth hormone response to exercise. J. Clin. Endocrinol. Metab., 76, 1418-1422, 1993.
70. Kanaley J.A., Weltman J.Y., Pieper K.S., Weltman A., Hartman M.L.: Cortisol and growth hormone responses to exercise at different times of day. J. Clin. Endocrinol. Metab. (In press)
71. Kanaley J.A., Weatherup-Dentes M.M., Jaynes E.B., Hartman M.L.: Obesity attenuates the growth hormone response to exercise. J. Clin. Endocrinol. Metab. 84, 3156-3161, 1999.
72. Weltman A., Weltman J.Y., Schurrer R., Evans W.S., Veldhuis J.D., Rogol A.D.: Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J. Appl. Physiol., 72, 2188-2196, 1992.
73. Deuschle M., Blum W.F., Frystyk J., Ørskov H., Schweiger U., Weber B., Körner A., Gotthardt U., Schmider J., Standhardt H., Heuser I.: Endurance training and its effect upon the activity of the GH-IGFs system in the elderly. Int. J. Sports Med., 19, 250-254, 1998.
74. Pyka G., Taaffe D.R., Marcus R.: Effect of a sustained program of resistance training on the acute growth hormone response to resistance exercise in older adults. Horm. Metab. Res., 26, 330-333, 1994.
75. nd Annual Meeting of the Endocrine Society, Toronto, Canada, June 21-24, 2000, abstract 1638, p. 396.